{"id":183112,"date":"2024-02-20T03:22:22","date_gmt":"2024-02-20T09:22:22","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/02\/lvhn-taking-part-in-clinical-trial-of-revolutionary-colorectal-cancer-treatment-that-saw-100-remission-in-patients"},"modified":"2024-02-20T03:22:22","modified_gmt":"2024-02-20T09:22:22","slug":"lvhn-taking-part-in-clinical-trial-of-revolutionary-colorectal-cancer-treatment-that-saw-100-remission-in-patients","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/02\/lvhn-taking-part-in-clinical-trial-of-revolutionary-colorectal-cancer-treatment-that-saw-100-remission-in-patients","title":{"rendered":"LVHN taking part in clinical trial of revolutionary colorectal cancer treatment that saw 100% remission in patients"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/lvhn-taking-part-in-clinical-trial-of-revolutionary-colorectal-cancer-treatment-that-saw-100-remission-in-patients2.jpg\"><\/a><\/p>\n<p>Memorial Sloan Kettering Cancer Center made waves earlier this year when it announced the completion of a clinical trial that saw colorectal cancer in 18 patients disappear.<\/p>\n<p>The patients received <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2201445\" target=\"_blank\">a drug<\/a> that helped their immune system target and attack cancer cells, driving <a href=\"https:\/\/www.nytimes.com\/2022\/06\/05\/health\/rectal-cancer-checkpoint-inhibitor.html\" target=\"_blank\">their cancer<\/a> <a href=\"https:\/\/www.nytimes.com\/2022\/06\/05\/health\/rectal-cancer-checkpoint-inhibitor.html\" target=\"_blank\">into remission and<\/a> <a href=\"https:\/\/www.nytimes.com\/2022\/06\/05\/health\/rectal-cancer-checkpoint-inhibitor.html\" target=\"_blank\">rendering it undetectable within six months<\/a>.<\/p>\n<p>Now, Lehigh Valley Health Network has joined a select group of networks and hospitals participating in the expanded clinical trial of the drug.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Memorial Sloan Kettering Cancer Center made waves earlier this year when it announced the completion of a clinical trial that saw colorectal cancer in 18 patients disappear. The patients received a drug that helped their immune system target and attack cancer cells, driving their cancer into remission and rendering it undetectable within six months. Now, [\u2026]<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495],"tags":[],"class_list":["post-183112","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/183112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=183112"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/183112\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=183112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=183112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=183112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}